angiotensin ii has been researched along with pervanadate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Hollenberg, MD; Laniyonu, A; Saifeddine, M | 1 |
| Hill, MA; Murphy, TV; Spurrell, BE | 1 |
| Hwang, SA; Jang, SH; Karnik, SS; Kim, M; Kim, MS; Lee, C; Yun, SH | 1 |
3 other study(ies) available for angiotensin ii and pervanadate
| Article | Year |
|---|---|
Regulation of vascular and gastric smooth muscle contractility by pervanadate.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blotting, Western; Calcium; Epidermal Growth Factor; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Sodium; Stomach; Tyrosine; Vanadates | 1994 |
Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension.
Topics: Angiotensin II; Animals; Antibody Specificity; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Colforsin; Endothelium, Vascular; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphorylation; Phosphotyrosine; Physical Stimulation; Rats; Rats, Sprague-Dawley; Tyrosine; Tyrphostins; Vanadates; Vasoconstriction; Vasodilator Agents; Verapamil | 2001 |
A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage.
Topics: Angiotensin II; Animals; Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Green Fluorescent Proteins; Hydrolysis; Molybdenum; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatases; Rats; Receptor, Angiotensin, Type 1; Transfection; Tyrosine; Vanadates; Vasoconstrictor Agents | 2009 |